CD4 and COVID-19: In response to polyclonal in vitro stimulation, the percentage of CD3+CD4+IL-2+ T cells showed a significant 4-fold decrease in the group that during the follow-up developed severe COVID-19 compared to participants experiencing mild symptoms (P = 0.0085) (Figure 2B).